Paromomycin in cryptosporidiosis [1] (multiple letters)

Clinical Infectious Diseases

Volumn 32, Issue 10, 2001, Pages 1516-1517

  White, A Clinton ^a   Cron, Stanley G ^b   Chappell, Cynthia L ^c  

^a Section of Infectious Diseases   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MACROLIDE; PAROMOMYCIN; PLACEBO; COCCIDIOSTATIC AGENT;

BLOOD CULTURE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; CYTOMEGALOVIRUS; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; HUMAN; LETTER; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MYCOBACTERIUM; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RELAPSE; SUPERINFECTION; TREATMENT FAILURE; TREATMENT OUTCOME; AIDS RELATED COMPLEX; ANIMAL; METHODOLOGY; NOTE; PARASITOLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; COCCIDIOSTATS; CRYPTOSPORIDIOSIS; HUMANS; PAROMOMYCIN; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 0035874374     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320171     Document Type: Letter

References (0)